VCEL
Vericel Corp

8,155
Mkt Cap
$1.65B
Volume
604,410.00
52W High
$48.75
52W Low
$29.24
PE Ratio
105.70
VCEL Fundamentals
Price
$32.54
Prev Close
$32.11
Open
$32.50
50D MA
$36.43
Beta
1.20
Avg. Volume
456,558.42
EPS (Annual)
$0.3167
P/B
4.64
Rev/Employee
$694,118.09
$1,838.72
Loading...
Loading...

About

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
398

Frequently Asked Questions

What is Market Cap of Vericel Corp?
What is the 52-week high for Vericel Corp?
What is the 52-week low for Vericel Corp?
What is Vericel Corp stock price today?
What was Vericel Corp stock price yesterday?
What is the PE ratio of Vericel Corp?
What is the Price-to-Book ratio of Vericel Corp?
What is the 50-day moving average of Vericel Corp?
How many employees does Vericel Corp have?

Latest VCEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.